Marimed (MRMD) Debt to Equity (2012 - 2023)

Marimed (MRMD) has 12 years of Debt to Equity data on file, last reported at $0.28 in Q3 2023.

• Debt to Equity for Q3 2023 came in at $0.28, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $0.28 (changed N/A YoY), and the FY2021 annual result was $0.48, down 67.47% from the prior year.
• Debt to Equity retreated to $0.28 in Q3 2023 per MRMD's latest filing, from $0.3 in the prior quarter.
• Over five years, Debt to Equity peaked at $153.66 in Q3 2020 and troughed at -$2.84 in Q2 2020.
• A 5-year average of $9.59 and a median of $0.15 in 2021 frame the typical range for Debt to Equity.
• On a YoY basis, Debt to Equity climbed as much as 3060128.43% in 2020 and fell as far as 304992.6% in 2020.
• A 5-year view of Debt to Equity shows it stood at $0.28 in 2019, then jumped by 427.16% to $1.46 in 2020, then sank by 67.47% to $0.48 in 2021, then tumbled by 99.78% to $0.0 in 2022, then jumped by 26589.78% to $0.28 in 2023.
• Business Quant data shows MRMD's Debt to Equity at $0.28 in Q3 2023, $0.3 in Q2 2023, and $0.37 in Q1 2023.